Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Chronic Kidney Disease and Diabetes”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Fees are shown only where DOAJ records them.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) |
|---|---|---|---|---|---|---|---|
| 1 | Clinical Journal of the American Society of Nephrology Lippincott Williams & Wilkins · United States | 99% | 80.1 | #2,124 | 1,425 | 96% | Not recorded |
| 2 | BMC Nephrology BioMed Central · United Kingdom · DOAJ | 100% | 77.5 | #3,081 | 2,491 | 100% | 2,790 EUR |
| 3 | Renal Failure Taylor & Francis · United States · DOAJ | 96% | 79.0 | #2,497 | 1,848 | 100% | 4,165 AUD |
| 4 | Clinical and Experimental Nephrology Springer Science+Business Media · Japan | 96% | 72.0 | #5,663 | 810 | 40% | Not recorded |
| 5 | Integrative Medicine in Nephrology and Andrology | 99% | 61.1 | #12,227 | 127 | 87% | Not recorded |
| 6 | Nephrology Wiley · Australia | 93% | 69.6 | #7,005 | 852 | 51% | Not recorded |
| 7 | Kidney Diseases Karger Publishers · Switzerland · DOAJ | 91% | 65.7 | #9,373 | 277 | 100% | 2,230 EUR |
| 8 | Kidney & Blood Pressure Research Karger Publishers · Switzerland · DOAJ | 84% | 68.4 | #7,763 | 415 | 100% | 2,690 CHF |
| 9 | Kidney Medicine Elsevier BV · United States · DOAJ | 83% | 67.7 | #8,157 | 982 | 100% | US$2,590 |
| 10 | Current Opinion in Nephrology & Hypertension Lippincott Williams & Wilkins · United States | 79% | 74.8 | #4,202 | 431 | 35% | Not recorded |
| 11 | Kidney International Supplements Elsevier BV · United States | 82% | 68.5 | #7,691 | 61 | 92% | Not recorded |
| 12 | Journal of Nephrology Springer Science+Business Media · Italy | 78% | 72.7 | #5,311 | 1,520 | 44% | Not recorded |
| 13 | Nature Reviews Nephrology Nature Portfolio · United Kingdom | 66% | 91.2 | #173 | 648 | 32% | Not recorded |
| 14 | Clinical Kidney Journal Oxford University Press · United Kingdom · DOAJ | 73% | 78.4 | #2,731 | 1,719 | 100% | Not recorded |
| 15 | International Journal of Nephrology and Renovascular Disease Dove Medical Press · New Zealand · DOAJ | 77% | 63.1 | #10,976 | 172 | 100% | US$3,565 |
| 16 | World Journal of Nephrology Baishideng Publishing Group · United States | 76% | 62.6 | #11,299 | 157 | 100% | Not recorded |
| 17 | Canadian Journal of Kidney Health and Disease SAGE Publishing · United Kingdom · DOAJ | 75% | 65.0 | #9,795 | 456 | 100% | US$2,000 |
| 18 | American Journal of Nephrology Karger Publishers · Switzerland | 66% | 73.2 | #5,053 | 496 | 50% | Not recorded |
| 19 | Kidney360 Lippincott Williams & Wilkins · United States · DOAJ | 66% | 68.9 | #7,447 | 1,614 | 100% | US$1,800 |
| 20 | International Journal of Nephrology Hindawi Publishing Corporation · United Kingdom · DOAJ | 70% | 59.6 | #13,177 | 152 | 100% | US$1,100 |
| 21 | American Journal of Kidney Diseases Elsevier BV · United States | 61% | 74.7 | #4,241 | 3,767 | 41% | Not recorded |
| 22 | Cardiorenal Medicine Karger Publishers · Switzerland · DOAJ | 65% | 68.2 | #7,875 | 209 | 100% | Not recorded |
| 23 | Brazilian Journal of Nephrology Sociedade Brasileira de Nefrologia · Brazil · DOAJ | 68% | 60.0 | #12,926 | 779 | 100% | Not recorded |
| 24 | Seminars in Nephrology Elsevier BV · United States | 62% | 72.2 | #5,599 | 380 | 37% | Not recorded |
| 25 | Kidney International Reports Elsevier BV · United States · DOAJ | 63% | 66.6 | #8,773 | 8,009 | 100% | US$3,100 |
| 26 | Kidney International Elsevier BV · The Netherlands | 47% | 92.9 | #99 | 2,272 | 52% | Not recorded |
| 27 | Nephrology Dialysis Transplantation Oxford University Press · United Kingdom | 56% | 75.0 | #4,119 | 9,378 | 64% | Not recorded |
| 28 | Journal of the American Society of Nephrology American Society of Nephrology | 57% | 70.3 | #6,589 | 21,194 | 7% | Not recorded |
| 29 | Kidney Research and Clinical Practice Elsevier BV · South Korea · DOAJ | 57% | 67.3 | #8,375 | 541 | 100% | Not recorded |
| 30 | Néphrologie & Thérapeutique Elsevier BV · France | 64% | 53.2 | #17,283 | 1,091 | 21% | Not recorded |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.